Advertisement

Related Videos

Welcome and Introduction to Vi3C

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Deborah Collyar: What's In It for Patients?

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Nov
20
Today In Oncology
One Surgery Could Prevent Most Ovarian Cancers
ASTRO Experts Comment on the Results of the SUPREMO Trial
SLNB Alone vs Lymphadenectomy in Cervical Cancer
Traditional Approval Granted to Tarlatamab-dlle for Extensive-Stage SCLC
Melanoma Cancer Cluster Found in Parts of Pennsylvania
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo